首页 | 本学科首页   官方微博 | 高级检索  
     


Usability and feasibility of consumer-facing technology to reduce unsafe medication use by older adults
Affiliation:1. Department of Health Policy and Management, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana;2. Regenstrief Institute, Indianapolis, Indiana;3. Department of Family Medicine, School of Medicine, Indiana University, Indianapolis, Indiana;4. Eskenazi Health, Indianapolis, Indiana;5. Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana;6. Department of Biostatistics, School of Medicine and Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana
Abstract:BackgroundMobile health technology can improve medication safety for older adults, for instance, by educating patients about the risks associated with anticholinergic medication use.ObjectiveThis study's objective was to test the usability and feasibility of Brain Buddy, a consumer-facing mobile health technology designed to inform and empower older adults to consider the risks and benefits of anticholinergics.MethodsTwenty-three primary care patients aged ≥60 years and using anticholinergic medications participated in summative, task-based usability testing of Brain Buddy. Self-report usability was assessed by the System Usability Scale and performance-based usability data were collected for each task through observation. A subset of 17 participants contributed data on feasibility, assessed by self-reported attitudes (feeling informed) and behaviors (speaking to a physician), with confirmation following a physician visit.ResultsOverall usability was acceptable or better, with 100% of participants completing each Brain Buddy task and a mean System Usability Scale score of 78.8, corresponding to “Good” to “Excellent” usability. Observed usability issues included higher rates of errors, hesitations, and need for assistance on three tasks, particularly those requiring data entry. Among participants contributing to feasibility data, 100% felt better informed after using Brain Buddy and 94% planned to speak to their physician about their anticholinergic related risk. On follow-up, 82% reported having spoken to their physician, a rate independently confirmed by physicians.ConclusionConsumer-facing technology can be a low-cost, scalable intervention to improve older adults’ medication safety, by informing and empowering patients. User-centered design and evaluation with demographically heterogeneous clinical samples uncovers correctable usability issues and confirms the value of interventions targeting consumers as agents in shared decision making and behavior change.
Keywords:Medications  Information technology  Shared decision making  Patient safety  User-centered design  Anticholinergics  Human factors engineering  Behavioral informatics  Mobile health (mHealth)  Digital health (eHealth)
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号